North American leukemia, intergroup phase III randomized trial of single agent clofarabine as induction and post-remission therapy, and decitabine as maintenance therapy in newly-diagnosed acute myeloid leukemia in older adults (age >= 60 years): A trial of the ECOG-ACRIN Cancer Research Group (E2906) Meeting Abstract

  

Authors:	Foran, J. M.; Sun, Z. X.; Claxton, D. F.; Lazarus, H. M.; Thomas, M. L.; Melnick, A.; Levine, R. L.; Paietta, E.; Arber, D.; Zhang, Y. M.; Rowe, J. M.; Godwin, J. E.; Altman, J. K.; Luger, S.; Al-Kali, A.; Zheng, H.; Pratz, K.; Broun, E. R.; Powell, B. L.; O'Dwyer, K.; Litzow, M. R.; Tallman, M. S.
Abstract Title:	North American leukemia, intergroup phase III randomized trial of single agent clofarabine as induction and post-remission therapy, and decitabine as maintenance therapy in newly-diagnosed acute myeloid leukemia in older adults (age >= 60 years): A trial of the ECOG-ACRIN Cancer Research Group (E2906)
Meeting Title:	57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	126
Issue:	23
Meeting Dates:	2015 Dec 5-8
Meeting Location:	Orlando, FL
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2015-12-03
Language:	English
ACCESSION:	WOS:000368019000281
PROVIDER:	wos
DOI:	10.1182/blood.V126.23.217.217
Notes:	Meeting Abstract: 217 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/91425